Argenx Se logo

Argenx Se Share Price Today

(NASDAQ: ARGX)

Argenx Se share price is $611.18 & ₹52,909.85 as on 19 Mar 2025, 2.30 'hrs' IST

$611.18

-3.01

(-0.49%)

Market is closed - opens 7 PM, 19 Mar 2025

View live Argenx Se share price in Dollar and Rupees. Guide to invest in Argenx Se stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Argenx Se, along with analyst recommendations, forecasts, and comprehensive financials.

Argenx Se share price movements

  • Today's Low: $607.39
    Today's High: $621.79

    Day's Volatility :2.32%

  • 52 Weeks Low: $349.86
    52 Weeks High: $678.21

    52 Weeks Volatility :48.41%

Argenx Se (ARGX) Returns

PeriodArgenx SeSector (Health Care)Index (Russel 2000)
3 Months
-1.6%
6.9%
0.0%
6 Months
16.09%
-5.5%
0.0%
1 Year
70.91%
1.3%
0.0%
3 Years
105.76%
7.1%
-15.2%

Argenx Se (ARGX) Key Statistics

in dollars & INR

Previous Close
$614.19
Open
$621.05
Today's High
$621.79
Today's Low
$607.39
Market Capitalization
$36.8B
Today's Volume
$291.9K
52 Week High
$678.21
52 Week Low
$349.86
Revenue TTM
$2.3B
EBITDA
$3.5M
Earnings Per Share (EPS)
$12.77
PE Ratio
47.37
Profit Margin
36.99%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
17.36%

How to invest in Argenx Se Stock (ARGX) from India?

It is very easy for Indian residents to invest directly in Argenx Se from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Argenx Se stock in both Indian Rupees (INR) and US Dollars (USD). Search for Argenx Se or ARGX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Argenx Se or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Argenx Se shares which would translate to 0.001 fractional shares of Argenx Se as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Argenx Se, in just a few clicks!

Returns in Argenx Se (ARGX) for Indian investors in Rupees

The Argenx Se stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Argenx Se investment value today

Current value as on today

₹1,74,396

Returns

₹74,396

(+74.4%)

Returns from Argenx Se Stock

₹70,070 (+70.07%)

Dollar Returns

₹4,326 (+4.33%)

Indian investors sentiment towards Argenx Se (ARGX)

57%

Period: Feb 16, 2025 to Mar 18, 2025. Change in 30 Days versus previous period

Search interest for Argenx Se Stock from India on INDmoney has increased by 57% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Argenx Se

  • FMR Inc

    9.25%

  • T. Rowe Price Associates, Inc.

    9.08%

  • Artisan Partners Limited Partnership

    5.05%

  • HHG PLC

    3.81%

  • Capital World Investors

    2.94%

  • venBio Select Advisor LLC

    2.04%

Analyst Recommendation on Argenx Se

Buy

    72%Buy

    24%Hold

    4%Sell

Based on 25 Wall street analysts offering stock ratings for Argenx Se(by analysts ranked 0 to 5 stars)

Based on 25 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
18
18
19
Hold
6
6
6
Sell
1
0
0

Analyst Forecast on Argenx Se Stock (ARGX)

What analysts predicted

Upside of 26.17%

Target:

$771.11

Current:

$611.18

Insights on Argenx Se Stock (Ticker Symbol: ARGX)

  • Price Movement

    In the last 1 year, ARGX stock has moved up by 69.9%
  • Decreasing Revenue

    Argenx SE has experienced a decline in revenue for the last two quarters. Specifically, revenue has decreased from $877.26 million to $573.23 million, resulting in an average decrease of 34.7% per quarter.
  • Increasing Net Profit

    Argenx SE has shown consistent improvement in its net profit over the last 6 quarters, rising from a loss of $94.36 million to a profit of $91.41 million. This represents an average quarterly increase of 54.6% in profit.
  • ARGX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 71.7% return, outperforming this stock by 1.8%
  • Price to Sales

    Argenx SE has a Price-to-Sales Ratio of $406.1, meaning investors are willing to pay $406.1 for every $1 of sales the company generates. In comparison, Alnylam Pharmaceuticals, Inc. has a much lower Price-to-Sales Ratio of $13.9 for every $1 of sales. This indicates that investors value Argenx SE significantly higher per dollar of sales than they do Alnylam Pharmaceuticals.

Argenx Se Technicals Summary

Sell

Neutral

Buy

Argenx Se is currently in a neutral trading position according to technical analysis indicators.

Argenx Se (ARGX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Argenx Se logo
-3.88%
16.09%
70.91%
105.76%
416.82%
Regeneron Pharmaceuticals, Inc. logo
-0.23%
-40.43%
-29.6%
-2.13%
54.73%
Beone Medicines Ltd logo
11.32%
34.36%
57.69%
47.57%
110.37%
Vertex Pharmaceuticals Incorporated logo
11.18%
8.35%
23.74%
105.29%
149.4%
Alnylam Pharmaceuticals, Inc. logo
1.24%
-7.34%
70.82%
55.83%
143.73%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Argenx Se logo
47.37
47.37
0.0
12.08
0.17
0.0
NA
90.85
Regeneron Pharmaceuticals, Inc. logo
17.39
17.39
0.98
42.83
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.45
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.43
18.06
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.52
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Argenx Se logo
Buy
$36.8B
416.82%
47.37
36.99%
Regeneron Pharmaceuticals, Inc. logo
Buy
$72.9B
54.73%
17.39
31.07%
Beone Medicines Ltd logo
NA
$28.9B
110.37%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$129.6B
149.4%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.3B
143.73%
NA
-12.37%

About Argenx Se

argenx SE, a biotechnology company, engages in the developing of various therapies for the treatment of autoimmune diseases in the United States, Japan, Europe, Middle East, Africa, and China. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, generalized myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, thyroid eye disease, bullous pemphigoid, myositis, primary sjögren's syndrome, post-covid postural orthostatic tachycardia syndrome, membranous nephropathy, lupus nephropathy, anca-associated vasculitis, and antibody mediated rejection; ENHANZE SC; Empasiprubart for multifocal motor neuropath, delayed graft function, and dermatomyositis; and ARGX-119 for congenital myasthenic syndrome and amyotrophic lateral sclerosis. The company is developing ARGX-213 targets FcRn; ARGX-121 and ARGX-220 targets immune system; ARGX-109 targets IL-6; ARGX-118 for inflammation; and ARGX-109, as well as cusatuzumab, ARGX-112, ARGX-114, and ARGX-115. It owns VYVGART; VYVGART HYTRULO; VYVDURA; ARGENX; ABDEG; NHANCE; SIMPLE ANTIBODY; and ARGENXMEDHUB. The company has strategic partnership with AbbVie S.À.R.L., Zai Lab Limited, and LEO Pharma A/S; and collaboration and license agreement with Genor Biopharma Co. Ltd, Université Catholique de Louvain, Sopartec S.A., NYU Langone Health, Leiden University Medical Center, AgomAb Therapeutics NV, Broteio Pharma B.V., VIB vzw, University of Texas, BioWa, Inc., and Shire International GmbH. It has collaboration agreement with Genmab A/S to discover, develop, and commercialize novel therapeutic antibodies with applications in immunology and oncology, as well as a strategic collaboration with IQVIA Holdings Inc. to provide safety systems and services. argenx SE was incorporated in 2008 and is based in Amsterdam, the Netherlands.
Organization
Argenx Se
Employees
0
CEO
Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Industry
Health Technology

Management People of Argenx Se

NameTitle
Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Co-Founder, CEO & Executive Director
Mr. Karl Gubitz
Chief Financial Officer
Ms. Karen Massey
Chief Operating Officer
Mr. Filip Borgions
VP & Global Head of Technical Operations
Mr. Peter Ulrichts
Chief Scientific Officer
Ms. Beth DelGiacco
VP and Global Head of Corporate Communications & Investor Relations
Ms. Malini Moorthy
General Counsel
Mr. Arjen Lemmen M.Sc.
Vice President of Corporate Development & Strategy
Mr. Marc Schorpion
Global Head of Human Resources
Ms. Andria Wilk
Global Head of Quality

Important FAQs about investing in ARGX Stock from India :

What is Argenx Se share price today?

Argenx Se share price today stands at $611.18, Open: $621.05 ; Previous Close: $614.19 ; High: $621.79 ; Low: $607.39 ; 52 Week High: $678.21 ; 52 Week Low: $349.86.

The stock opens at $621.05, after a previous close of $614.19. The stock reached a daily high of $621.79 and a low of $607.39, with a 52-week high of $678.21 and a 52-week low of $349.86.

Can Indians buy Argenx Se shares?

Yes, Indians can invest in the Argenx Se (ARGX) from India.

With INDmoney, you can buy Argenx Se at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Argenx Se at zero transaction cost.

How can I buy Argenx Se shares from India?

It is very easy to buy Argenx Se from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Argenx Se (ARGX) be purchased?

Yes, you can buy fractional shares of Argenx Se with INDmoney app.

What are the documents required to start investing in Argenx Se stocks?

To start investing in Argenx Se, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Argenx Se Stock (ARGX)?

Today’s highest price of Argenx Se (ARGX) is $621.79.

Today’s lowest price of Argenx Se (ARGX) is $607.39.

What is today's market capitalisation of Argenx Se?

Today's market capitalisation of Argenx Se ARGX is 36.8B

What is the 52 Week High and Low Range of Argenx Se Stock (ARGX)?

  • 52 Week High

    $678.21

  • 52 Week Low

    $349.86

What are the historical returns of Argenx Se (ARGX)?

  • 1 Month Returns

    -3.88%

  • 3 Months Returns

    16.09%

  • 1 Year Returns

    70.91%

  • 5 Years Returns

    416.82%

Who is the Chief Executive Officer (CEO) of Argenx Se ?

Mr. Timothy Van Hauwermeiren EMBA, M.Sc. is the current Chief Executive Officer (CEO) of Argenx Se.